Recent cohort studies have shown an association between higher serum concentrations of FGF23 and frailty in elderly people, independently of phosphorus levels or other markers of mineral metabolism, both in patients predominantly without CKD (30) and patients with CKD (31). Here, FGF23 is linked to chronic kidney disease.